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ABSTRACT
Purpose: Tumor banks have the primary responsibility for collecting, cataloging, storing and disseminating samples of 
tissues, cells and fluids, which are used by researchers to identify diagnostic molecular markers, prognostic indicators and 
therapeutic targets. The objective of this review was to describe a simple, reliable and reproducible protocol for obtaining 
and storing samples of urological tumors.
Materials and Methods: Urogenital tumor tissues were collected by the surgeons from the Urology Division of University 
of Sao Paulo Medical School. The obtained surgical specimens were immediately placed in liquid nitrogen, dry ice or in 
a tube containing RNAlater ®, and then stored by cryopreservation (-80°C). A mirror fragment was fixed in 10% formalin 
processed routinely and embedded in Paraplast®.
Results: We developed a protocol for the collection, cataloging, storage, conservation and use of tumor samples. During 
a period of one year the Urological Tumor Bank of the Urology Division stored 274 samples of prostate, bladder, kidney, 
penis and testicle tumors of different histological types, 74 urine and 271 serum samples.
Conclusions: Having biological materials characterized and available along with the clinical patient information provides 
an integrated portrait of the patients and their diseases facilitating advances in molecular biology. It also promotes the 
development of translational research improving methods of diagnosis and cancer treatment.
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INTRODUCTION
 According to the Council of Europe, (1997), 
in Commentary 137 to article 22, “a tumor bank is an 
organization responsible for collecting, cataloging, 
storing and disseminating samples of tissues, cells and 
fluids for the investigation of diagnostic molecular 
markers, definition of prognosis and identification of 
therapeutic targets (1), for facilitating the discovery of 
 Basi�� an�� Translational Urology   
��oi: 10.1590/S1677-55382010000300012 
new therapies and new drugs, and for other applica-
tions yet to be discovered” (2).
 All organs of the urogenital tract are potential 
targets of malignant tumors, and although prostate 
cancer has the higher incidence, there is a need for 
the study of tumors of the bladder, kidney, urethra, 
testicles and penis to help optimize methods to be 
applied in diagnosis, prognosis and treatment of these 
diseases. The tumor bank of the Urology Division at 
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the University of Sao Paulo Medical School (USPMS) 
was established in 2008 and differs from the other 
banks by storing only samples of urological tumors, 
in order to increase the number of basic studies and 
clinical research.
 Brazil has three major banks that store tumor 
specimens of various types of cancer: the Barretos 
Cancer Hospital has 19,000 samples, AC Camargo 
Cancer Hospital has 13,000 samples and the National 
Cancer Institute has 7,000 samples.
 The objective of this review was to describe 
a simple, reliable and reproducible protocol for ob-
taining and storing samples of urological tumors; to 
clarify basic concepts related to tumor banks, their 
organization, relevance, quality and ethics; and to 
describe the tumors in the bank created by the Urol-
ogy Division of USPMS.
 Two principles are fundamental for good 
basic and clinical research: the accuracy of clinical 
information and outcome of patients treated by cancer 
and the quality of tumor samples that will allow the 
search for molecular abnormalities involved with 
neoplastic development and progression. A tumor 
bank with an effective protocol allows researchers 
to store and access tumor tissue samples under ideal 
conditions for research and recovery of patient data 
(3). This systematic organization of information al-
lows the development of cancer research with solid 
scientific conclusions (4).
 According to Teodorovic et al. (5) tumor 
banks contribute to translational research by promot-
ing more and better integration between clinicians 
and researchers. Translational research is an integra-
tion of clinical and laboratory research aiming the 
improvement of prevention, diagnosis and treatment 
of diseases via the practical application of scientific 
discoveries (5-7). The identification of a tumor or a 
biological marker allows a better understanding of 
the pathology, diagnosis, prognostic indicators, most 
appropriate therapy and the potential of recurrence. 
For example, prostate-specific antigen serves as a 
marker for prostatic cancer (5) and is used by urolo-
gists to better assess patients and to obtain greater 
precision in evaluating the diverse characteristics of 
the disease.
 According to Alimena et al. (4), the idea of 
using a therapy that reaches only the neoplastic cells 
and the identification of markers capable of distin-
guishing sensitive patients from patients resistant to 
first-line therapy are both the result of the creation of 
tissue banks.
 Pathologists and molecular biologists have 
been responsible for such studies, conducting labo-
ratory research with the practical goal of not only 
contributing to clinical knowledge, but also guiding 
the clinician in the evaluation of patients (4). Chu et 
al. (8) described molecular biology as a discipline that 
uses the techniques available to study diseases and 
their implications.
 The tumor bank of the Urology Division of 
USPMS was created with the goal of aiding a new 
line of research in urological oncology. Having these 
biological materials available and characterized, along 
with the clinical information of the patients, provides 
an integrated portrait of the patients and their illnesses, 
enabling advances in molecular biology. Tumor banks 
may be useful in the future because constant medical 
and technological advances in early diagnosis and 
pre-operative therapies will reduce the number of 
surgeries for tumor removal, thus jeopardizing the 
collection of tumor tissues. Therefore, a network of 
tumor banks must be organized to ensure appropriate 
and responsible use of the materials (9).
 Informatics (10) can facilitate patient regis-
tration, specimen tracking, tissue cataloguing, quality 
assurance, and specimen availability. The ability of 
databases to organize and present desired information 
can also aid in tracking informed consent and institu-
tional compliance and be could used to generate tissue 
bank inventory reports to match investigator requests 
with specimen availability.
 The components of a system must be faultless 
in order to allow efficient data entry, queries and report 
preparation, and must also allow rapid deployment 
of new services. The Urology Division of USPMS 
has a computer software exclusively established for 
the function of its tumor bank and also an electronic 
file system that allows the professionals involved in 
research to gain access to all clinical and laboratory 
information from each patient.
 Each country defines the rules it believes are 
necessary to protect its citizens. Few countries, includ-
ing Iceland and Sweden, have a law specifically related 
to tumor banks. The majority have Research Ethics 
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Committees (REC) that has to approve research that 
will use the samples of tumor banks, acting only once 
the tissue is stored but not for storage of samples.
 Oosterhuis et al. (2) summarized the princi-
ples to which all tumor banks must comply: i) Protect 
the interests of donors; ii) Give patients full informa-
tion about the project and appropriate research; iii) 
Uphold and ensure the balance between the interests 
of science and donors; iv) Prohibit the commercial 
use of human tissue.
 In Brazil, the ethical issues related to research 
activities involving human beings are governed by the 
Guidelines and Standards for Research in Human Be-
ings, introduced by Resolution 196/96 of the National 
Health Council (11). Resolution 347/05 regulates 
the storage and use of human biological material for 
research purposes (12).
 According to Resolution 196/96, the respect 
due to human dignity requires that all research is 
conducted after free and informed consent of patients. 
The patient must sign a form to agree that their mate-
rial can be included in the tumor bank, and when that 
material is part of a study approved by the tumor bank 
and the REC, the patient must be contacted and has 
to sign an additional form referring to the study that 
seeks the material. In cases where it is impossible to 
obtain the consent of the patient (e.g. death,), this fact 
must be documented with an explanation of the cause 
of failure and the opinion of the REC.
 Resolution 347 states that the REC should be 
informed of the formation of a tumor bank and of its 
objectives and responsibilities.
MATERIALS AND METHODS
Standard Operational Procedure of the 
Urological Tumor Bank
 Biological materials are stored by cryopreser-
vation (-80°C) and in paraffin blocks (Table-1). After 
surgical specimens are removed, the fresh tissue is 
immediately placed in liquid nitrogen, dry ice or in a 
tube containing RNAlater ® (a solution that preserves 
the genetic material of the tissue for a longer period), 
which is then stored at -80°C. The freezer is localized 
in a special room designed for -80ºC freezers where 
freezer temperature is controlled 24 h by a comput-
erized system MV2000 (Yokogawa). Additionally a  
generator is installed to supply the equipment in case 
of energy failure. The material is available only to      
accredited researchers in the Urology Division and is 
used after approval of the REC. A mirror fragment of 
the specimen frozen is fixed in 10% buffered formalin 
routinely processed and embedded in Paraplast®. Cen-
tral morphologic reviews are performed on the for-
malin-fixed samples, including assessment of tumor 
diagnosis, percent of tumor, stroma, and necrosis.
 The physician responsible for the surgery 
is also responsible for the collection of the Consent 
Form and the tumor sample. Immediately after surgi-
cal removal, a fragment of the tumor is removed and 
put into a plastic tube resistant to low temperatures 
with  RNAlater ® and is immediately labeled with a 
code for identification.
Table 1 – Procedure for storage of collected tissue.
Cryopreservation (- 80°C) Embedding in Paraplast®
Benefits Benefits
Morphological studies of high quality Cheaper
Molecular, immunohistochemical and cytogenetic analyses Half-life unlimited
Extraction of high quality DNA, RNA and protein Histological morphology of high quality
Disadvantages Disadvantages
Half-life: 1 decade or more The genetic material may be damaged
More expensive and more difficult
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 At the tumor bank of the Escola Paulista de 
Medicina / UNIFESP (4), as well as in our bank, the 
procedure is performed in the operating room with the 
patient anesthetized or under regional blockade. The 
collection neoplastic tissue samples are performed 
with a scalpel in the areas affected by the tumor. A 
preliminary assessment of the material is performed 
by direct palpation in areas more representative of 
the tumor. Then fragments are removed to provide 
material for pathological and genetic studies. The 
minimum size accepted for samples to be stored in a 
bank is 0.5 x 0.5 x 0.3 cm. Completion of the identi-
fication data for the donor and the identification data 
for the sample of tissue is the sole responsibility of 
the technical team.
 An important issue related to the collection 
of surgical specimens for tumor banking in urology 
is the histological verification process. This is neces-
sary due the potential risk that no tumor is present in 
the collected fragments. It can occur in cases where 
the tumor volume is small or not able to be seen as 
in prostate cancer specimens. Therefore, before bank-
ing, the obtained tissue needs to be histologically 
verified to ascertain the presence of neoplasic cells. 
The mirror fragment fixed in formalin and embedded 
in Paraplast® is the better solution for this problem. 
But in cases where this procedure has not been done, 
before the experiments using the samples, a slide 
should be cut in a cryostat and stained in hematoxylin 
and eosin to verify the presence and amount of tumor 
represented in that specific tissue fragment.
 Another important aspect is the precise site 
of fragment collection, especially for large tumors. 
A 10 cm kidney cancer may show histological and 
molecular heterogeneity when different parts of the 
tumor are examined. In bladder tumors, although the 
large amount of exophytic tumor appears homoge-
neous macroscopically, the bladder tumor base may 
be different at the molecular level. For this reason, our 
collecting protocol mandates that at least two different 
areas should be sampled for each case.
 A nurse is responsible for collecting blood 
and urine, for labeling the samples and placing 
them in cold storage. A biologist is responsible for 
collecting all the material, processing the samples, 
cataloging them and storing them in a freezer at -
80°C.
 If there is any problem with the tube used to 
store the tissue, it must be discarded and replaced. The 
samples should not remain more than 30 minutes with-
out optimal storage conditions to prevent degradation 
of genetic material (DNA, RNA and proteins).
 Another aspect that deserves mention is 
biosafety. Sastre-Garau (13) advised that the team 
involved must treat all materials as if they were 
contaminated, as there are risks inherent in handling 
biological samples, which could be infected by patho-
gens such as virus from human immunodeficiency and 
hepatitis B and C.
Infrastructure
 There are minimum requirements for the op-
eration of a tumor bank. A liquid nitrogen container 
or a -80°C freezer is required for sample storage, and 
thus physical space for these systems is necessary. 
Space is also required for processing the samples, 
the freezing unit,  RNAlater ® later, media storage 
(boxes and tubes), computer equipment (computer 
and printer) and the team (physicians’ surgeons, 
pathologists and nurse biologist). A continuous ac-
counting system is essential in tumor banking to 
control the withdrawals and inclusion of samples at 
any time.
Auditing
 An external audit is also necessary to ensure 
adequacy and quality control for any tumor bank. We 
acknowledge that the tumor bank must have a large 
numbers of samples sufficient for the completion 
and validation of any type of protocol but the most 
important aspect is the quality of the stored material, 
verified and complemented by ongoing clinical data 
accrual instead of sample size.
 The establishment of a tumor bank in large 
hospitals has some advantages as a large and diverse 
population which is available at our Institution. Our 
tumor bank has been in existence for approximately 
one year and already has large numbers of samples 
that have been used in various studies involving uro-
logical neoplasms.
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RESULTS
 From August 2008 to June 2009 we collected 
274 samples from different urogenital tumors as de-
scribed in Table-2. There are also 74 urine and 271 
serum samples that have been collected just before 
surgical procedure.
COMMENTS
 Understanding cancer at the molecular level 
is a very important step for the identification of new 
markers for diagnosis and prognosis of cancer, rep-
resenting a chance to create opportunities to develop 
target therapy. For this reason, it is of great importance 
to build a tumor collection in good storage conditions 
(2).
 Urological tumors are a serious clinical 
problem, as they include high prevalence neoplasms 
such as prostate cancer and aggressive tumors such 
as kidney and bladder carcinomas. With the develop-
ment of molecular biological techniques, the use of 
human neoplastic tissue is of great importance for 
cancer research. Therefore, we were prompted to be-
gin development of protocols with extensive clinical 
and surgical data in order to create a tumor bank.
 Regarding the storage of tumors, there are 
advantages and disadvantages to storing samples in 
a -80°C freezer and freezing in liquid nitrogen. The 
benefits of the freezer are the ability to store about 
15,000 2 mL Eppendorf tubes, with easy access and 
less infrastructure requirement. The disadvantages are 
the high cost, the fragility of the equipment and its 
dependence on energy (4). To solve this problem there 
are liquid nitrogen backups that keeps the freezer at 
low temperature when lack of energy occurs, however 
only for a short period of time.
 Storage in liquid nitrogen renders the ac-
cess of the specimens difficult and requires constant 
maintenance of the level of nitrogen. The advantages 
are preservation at -170ºC and independence from 
energy (13). We chose to store the tumor bank in a 
-80°C freezer. It is important to mention that freezers 
must be routinely checked to guarantee the constant 
temperature, crucial for the maintenance of integrity 
of surgical specimens, urine and serum. Also, a back-
up of gas supply or generator is imperative in case of 
electric energy failure. In our case we have a room in 
the main building of University of Sao Paulo Medical 
School specially designed for -80ºC freezers contain-
ing a computerized system for temperature control 
and generators.
 It is imperative to record basic information 
from patients and their diseases to make a tumor 
bank useful for science. Gender, age, clinical and 
histopathological diagnoses, TNM classification, 
specification about a tumor as primary, metastatic or 
recurrent, occurrence of a previous treatment, type 
of sample, and most importantly the outcome of the 
patients should be recorded and be easily retrieved 
when necessary (14).
 Finally, we must make clear that the benefits 
offered by research with human tumor or normal tis-
sue from donors do not negate the serious and com-
plex issues of medical-legal ethics. All information 
provided must be maintained in a way that guarantees 
donor anonymity. We also emphasize that the main 
goal of research must first be to afford some benefit 
to the patient and not to the researcher (8).
CONCLUSION
 A tumor bank can be an instrument of great 
help for scientific research, as it offers tumor samples 
to researchers that have been stored under optimum 
Table 2 – All material collected from the tumor bank of the 
Division of Clinical Urology, Oncology sector from August 
2008 to June 2009.
Anatomical Location of the Tumor Quantity
Tumor samples
Prostate  130
Bladder    83
Kidney    51
Penis    03
Testicle    07
Total  274
Serum   271
Urine   74
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conditions of preservation. Through analysis of these 
samples, the researcher can better understand the can-
cer regarding the diagnosis, prognosis, prophylaxis 
and treatment. A well-organized and structured tumor 
bank facilitates and enables basic research discoveries 
that can improve population health.
 The disclosure of the protocol used by the uro-
logical tumor bank of the Urology Division of USPMS 
should assist other centers in training. Standardization 
of the handling of the specimens, collection and stor-
age and having a link between tumor banks will also 
increase the quantity and scope of research through 
the exchange of samples. In addition, by comparing 
information from databases at different locations, the 
regional characteristics of tumors can be studied and 
related to the habits of the respective populations.
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EDITORIAL COMMENT
 That paper of Reis and co-workers is of 
great importance in the field of research since that 
will allow studies on a very well organized source of 
human materials kept in very good conditions. It is 
very important to save a lot of tissues (together with 
blood) and for many years. Thus, in order to avoid 
any problems and to meet scientists requirements for 
research project it is necessary to save duplicates / 
triplicates of tissues in at least two different places 
(not necessary in the same city). It is well known that 
saving tissues in only one -80°C freeze is danger-
ous and it is better to have different banks in order 
to avoid any problems of safety (in case of electric 
power defect) and security. I would suggest also to 
have a website in order to inform people in your 
country about the relevance of that bank and thus 
organize meeting for future scientific projects in that 
area. What is also important to consider is the cost 
of keeping these samples for many years with highly 
specialized apparatus as well as technicians who must 
be aware of these conditions.
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